Cytokinetics, Incorporated (CYTK)

NASDAQ: CYTK · Real-Time Price · USD

70.91

-1.18 (-1.64%)

At close: Aug 31, 2026, 4:00 PM EDT

70.90

-0.01 (-0.01%)

After-hours: Aug 31, 2026, 5:38 PM EDT

Cytokinetics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	67.67	88.04	18.47	7.53	7.59	70.43
Other Revenue	-	-	-	-	87	-
Revenue	67.67	88.04	18.47	7.53	94.59	70.43
Revenue Growth	-21.07%	376.56%	145.34%	-92.04%	34.30%	26.15%
Cost of Revenue	405.11	416.03	339.41	330.12	240.81	159.94
Gross Profit	-337.44	-327.99	-320.93	-322.59	-146.23	-89.51
Selling, General & Admin	370.47	284.27	215.31	173.61	177.98	96.8
Operating Expenses	370.47	284.27	215.31	173.61	177.98	96.8
Operating Income	-707.91	-612.26	-536.25	-496.21	-324.2	-186.31
Interest Expense	-124.82	-103.87	-86.51	-57.67	-51.16	-29.33
Interest & Investment Income	46.68	48.42	51.53	27.63	11.34	0.33
Other Non Operating Income (Expenses)	13.3	4	-18.3	-	-	-
EBT Excluding Unusual Items	-772.75	-663.71	-589.53	-526.24	-364.02	-215.31
Other Unusual Items	-121.25	-121.25	-	-	-24.94	-
Pretax Income	-894	-784.96	-589.53	-526.24	-388.96	-215.31
Net Income	-894	-784.96	-589.53	-526.24	-388.96	-215.31
Net Income to Common	-894	-784.96	-589.53	-526.24	-388.96	-215.31
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	124	120	112	97	90	77
Shares Outstanding (Diluted)	124	120	112	97	90	77
Shares Change	5.07%	7.26%	16.01%	7.46%	16.83%	19.16%
EPS (Basic)	-7.18	-6.54	-5.26	-5.45	-4.33	-2.80
EPS (Diluted)	-7.18	-6.54	-5.26	-5.45	-4.33	-2.80
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-580.72	-534.82	-399.8	-415.75	-310.85	-191.39
Free Cash Flow Per Share	-4.67	-4.45	-3.57	-4.31	-3.46	-2.49
Gross Margin	-	-	-	-	-154.59%	-127.09%
Operating Margin	-1046.12%	-695.44%	-2902.72%	-6589.71%	-342.75%	-264.54%
Profit Margin	-1321.12%	-891.60%	-3191.11%	-6988.63%	-411.21%	-305.72%
Free Cash Flow Margin	-858.16%	-607.48%	-2164.10%	-5521.23%	-328.64%	-271.76%
EBITDA	-695.36	-602.13	-526.72	-484.31	-318.39	-184.04
EBITDA Margin	-	-	-	-	-	-261.31%
D&A For EBITDA	12.55	10.13	9.53	11.89	5.81	2.28
EBIT	-707.91	-612.26	-536.25	-496.21	-324.2	-186.31
EBIT Margin	-	-	-	-	-	-264.54%
Revenue as Reported	67.67	88.04	18.47	7.53	94.59	70.43

SEC Filings: 10-K · 10-Q